Answers are grounded in this paper and cite their sources.
Long-term follow-up reports outcomes of riluzole treatment in spinocerebellar ataxia type 7, highlighting the potential of drug repurposing for symptomatic management.
Currently no curative treatment exists for spinocerebellar ataxias (SCAs). Riluzole repurposing was proposed as a symptomatic treatment in different types of cerebellar ataxia. We report a long-term-follow up under riluzole treatment in SCA type 7.
No takes yet. Share an insight, caveat, or question.
Suppiej et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: